Weak US demand for Panadol maker Haleon's products pushes 2026 target below forecast

Haleon, British healthcare group which also produces products like Sensodyne toothpaste, employs 1,700 people across four locations in Ireland

Haleon in Waterford is the global home of Panadol where 6.5 billion tables are made each year.

Panadol maker Haleon forecast 3% to 5% growth in 2026 organic revenue, shy of its medium-term target as softer demand in its largest market, the US, weighed on sales.

The British healthcare group, which also produces products like Sensodyne toothpaste, posted fourth-quarter organic revenue growth of 2.1%, slower than the previous quarter and below some analysts' estimates, hurt by a mild cold and flu season in key markets. Organic revenues exclude currency moves and recent deals.